CA2192456A1 - Pyridylbisphosphonates a titre d'agent therapeutique - Google Patents

Pyridylbisphosphonates a titre d'agent therapeutique

Info

Publication number
CA2192456A1
CA2192456A1 CA002192456A CA2192456A CA2192456A1 CA 2192456 A1 CA2192456 A1 CA 2192456A1 CA 002192456 A CA002192456 A CA 002192456A CA 2192456 A CA2192456 A CA 2192456A CA 2192456 A1 CA2192456 A1 CA 2192456A1
Authority
CA
Canada
Prior art keywords
pyridylbisphosphonates
therapeutical agent
bone diseases
pyridinylaminomethylidene
tetralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002192456A
Other languages
English (en)
Other versions
CA2192456C (fr
Inventor
Marjaana Heikkila-Hoikka
Hannu Nikander
Ritva Hannuniemi
Leena Lauren
Terttu Kleimola
Sirpa Liukko-Sipi
Kalervo Vaananen
Raija Sellman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9402001A external-priority patent/SE9402001D0/xx
Application filed by Individual filed Critical Individual
Publication of CA2192456A1 publication Critical patent/CA2192456A1/fr
Application granted granted Critical
Publication of CA2192456C publication Critical patent/CA2192456C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002192456A 1994-06-09 1995-06-02 Pyridylbisphosphonates a titre d'agent therapeutique Expired - Lifetime CA2192456C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9402001-3 1994-06-09
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent
PCT/FI1995/000315 WO1995033466A1 (fr) 1994-06-09 1995-06-02 Pyridylbisphosphonates a titre d'agent therapeutique

Publications (2)

Publication Number Publication Date
CA2192456A1 true CA2192456A1 (fr) 1995-12-14
CA2192456C CA2192456C (fr) 2006-08-01

Family

ID=36764267

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002192456A Expired - Lifetime CA2192456C (fr) 1994-06-09 1995-06-02 Pyridylbisphosphonates a titre d'agent therapeutique

Country Status (1)

Country Link
CA (1) CA2192456C (fr)

Also Published As

Publication number Publication date
CA2192456C (fr) 2006-08-01

Similar Documents

Publication Publication Date Title
EP1029540A3 (fr) Utilisation de la droloxifène pour le traitement de maladies cardiovasculaires
AU5384096A (en) Use of vitamin D2 or vitamin D4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
CA2264097A1 (fr) Emploi du chelateur clioquinol pour produire une preparation pharmaceutique traitant la maladie d'alzheimer
SE8704248D0 (sv) Medical use
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
CA2188567A1 (fr) Composition pour acides bisphosphoniques a granulation par voie humide
AU2569895A (en) Pyridylbisphosphonates for use as a therapeutical agent
CA2200651A1 (fr) Preparation d'alendronate de sodium pour administration locale
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
EP0341961A3 (fr) Acides polymaloniques comme agents ayant une affinité osseuse
AU1945495A (en) Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
AU3530095A (en) Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
CA2213794A1 (fr) Medicament pour prevenir ou traiter la maladie d'alzheimer
CA2301706A1 (fr) Utilisation de phanquinone dans le traitement de la maladie d'alzheimer
SE8903529D0 (sv) Medical use
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments
HUP9802219A3 (en) Processes for the preparation of n-phosphonomethylglycine from n-phosphonomethyliminodiacetic acid
CA2192456A1 (fr) Pyridylbisphosphonates a titre d'agent therapeutique
MX9606180A (es) Piridilbisfosfonatos para utilizarse como un agente terapeutico.
CA2340920A1 (fr) Procede prevenant l'apparition de l'asthme
FR2778104B1 (fr) Utilisation d'un vecteur d'ions fluorure pour la preparation d'un medicament destine a la prevention ou au traitement de maladies associees a helicobacter pylori
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation
IT1269823B (it) Difosfonati e loro impiego farmacologico nel trattamento dell'osteoporosi
GEP20002179B (en) Means for Treatment of Herpes

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150602